Clinical Trial

Tuberculosis Clinical Registry in Europe

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The TBnet registry is a multinational, prospective tuberculosis registry established by the Tuberculosis Network European Trialsgroup (TBnet e.V.) to collect and analyze long-term data from TB patients across Europe. Its purpose is to centralize data on TB epidemiology, prevention, diagnosis, and treatment to improve care, support research, and ultimately help eliminate TB. The registry captures risk factors, diagnostic details (e.g., microbiology, imaging, drug resistance), treatment data, side effects, outcomes, and late complications.
Trial Details
NCT Number NCT07677904
Lead Sponsor Research Center Borstel
Collaborators: European Society of Clinical Microbiology and Infectious Diseases, Tuberculosis Network European Trialsgroup (TBnet e.V.)
Conditions Tuberculosis
Enrollment 1,000 participants
Start Date 2026-07
Primary Completion 2040-12 (estimated)
Study Completion 2040-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-01